Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

Caitlin E. Cox

February 02, 2026

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

L.A. McKeown

December 17, 2021

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Shelley Wood

November 15, 2021

News Daily News

Experts Fear Coronary CT Advice for Patients Misses the Mark

Michael O'Riordan

March 19, 2021

News Daily News

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Yael L. Maxwell

August 27, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for January 2026

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

June 2025 Dispatch for the CV Team

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

Statins Are Cost-effective in the Elderly

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

December 2023 Dispatch for the CV Team

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Experts Fear Coronary CT Advice for Patients Misses the Mark

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content